细胞外囊泡在输血相关不良反应中的潜在机制:最近的进展
概括
血液成分在储存期间释放细胞外囊泡 (EVs),这可能导致输血不良反应. 了解这些EV和使用蛋白质组学可以帮助减少输血风险.
科学领域:
- 输血医学 输血医学
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
背景情况:
- 输血是关键的医疗治疗,但储存的血液成分释放细胞外囊泡 (EVs).
- 这些EVs,小的脂质结合颗粒,具有促炎,凝固和免疫抑制作用.
- 它们在输血不良反应中的作用是越来越多的研究领域.
研究的目的:
- 探索由血衍生的EVs为输血相关的不良反应作出贡献的机制.
- 讨论蛋白质组学在分析输血医学中EV的应用.
- 确定减少与EVs相关的输血风险的策略.
主要方法:
- 文献综述侧重于输血中的细胞外囊泡.
- 血液生成源EVs的病理生理效应的分析.
- 探索用于EV表征的蛋白质组学工具.
主要成果:
- 血衍生的EVs可以通过各种生物效应促进或抑制疾病表型.
- 储存期间释放的EV与输血相关的不良事件有关.
- 保护学为详细的EV分析提供了先进的功能.
结论:
- 细胞外囊泡在输血相关的不良反应中起着重要作用.
- 先进的蛋白质组学可以提高对输血医学中EVs的理解和分析.
- 对电动车的进一步研究对于改善输血安全至关重要.
相关概念视频
Blood Transfusion and Agglutination
10.7K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.7K
Blood Transfusion
452
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
452
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Allergic Drug Reactions
800
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
800
Extrinsic and Intrinsic Pathways of Hemostasis
4.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
4.3K
Cell-mediated Immune Responses
66.5K
Overview
66.5K


